Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 36, Issue 7, 1992, Pages 1441-1446

  Condra, J H ^a   Emini, E A ^a   Gotlib, L ^a   Graham, D J ^a   Schlabach, A J ^a   Wolfgang, J A ^a   Colonno, R J ^a   Sardana, V V ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 CYCLOPROPYL 5,6 DIHYDRO 4 METHYL 11H PYRIDO[3,2 B]PYRIDO[3,2 E][1,4]DIAZEPIN 6 ONE; 3 [(4,7 DIMETHYL 2 BENZOXAZOLYLMETHYL)AMINO] 5 ETHYL 6 METHYL 2(1H) PYRIDONE; 4,5,6,7 TETRAHYDRO 5 METHYL 6 (3 METHYL 2 BUTENYL)IMIDAZO[4,5,1 JK][1,4]BENZODIAZEPINE 2(1H) THIONE; 9 CHLORO 4,5,6,7 TETRAHYDRO 5 METHYL 6 (3 METHYL 2 BUTENYL)IMIDAZO[4,5,1 JK][1,4]BENZODIAZEPINE 2(1H) THIONE; ANTIVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; NEVIRAPINE; PYRIDONE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CROSS RESISTANCE; DNA SEQUENCE; DRUG SENSITIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME INHIBITOR INTERACTION; GENE LOCATION; GENE LOCUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION;

EID: 0026638419     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.36.7.1441     Document Type: Article

References (0)